Pharmacy

At AMCP, four stakeholders representing the specialty pharmacy perspective, manufacturer perspective, payer perspective, and PBM perspective shared their thoughts on the future of specialty pharmacy.

At the AMCP16 conference, Managed Healthcare Executive invited some of the nation’s leading pharmacy and managed care experts to join us to discuss some of the most critical managed care pharmacy challenges facing the industry.

The CEO of the Academy of Managed Care Pharmacy identifies key challenges and opportunities that will be discussed at the annual meeting.

A new report from IMS Institute for Healthcare Informatics finds that biosimilar acceptance will grow and drive change in the healthcare system.

The death rate from overdoses involving benzodiazepines, a class of sedatives that includes Xanax, Valium, and Klonopin, has increased more than four-fold since 1996, according to a study appearing online in the American Journal of Public Health.

Here are 10 solutions that come together to provide a multifaceted approach to medication adherence.

This year’s Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting 2016, held April 19 to 22 in San Francisco, will feature several sessions of important to managed care professionals. Here are our top 10 recommendations.

Some experts argue that prescription drug monitoring programs can be a game changer when it comes to curbing prescription abuse and misuse. Here are 11 states that stand out for their PDMPs (or lack thereof).

A number of traditional brand-name pharmaceuticals have lost, or will lose, patent protection this year. What does this mean over the longer-term for controlling costs?

PCSK9 inhibitor benefits patients with statin intolerance

The approaches reflect a growing number of initiatives meant to tie drug prices to value. Find out more.

The sheer volume of diabetes patients has made it a big driver of medication spending. Here are some important formulary considerations.

Industry insiders believe that the Anthem lawsuit against Express Scripts over drug pricing may provide some clues into this complex situation.

An in-depth look at the effects of PDMPs, which are electronic databases used to track the prescribing and dispensing of controlled prescription drugs to patients.

While the high cost of specialty pharmacy is no surprise in the healthcare industry, infusibles have additional challenges. Here are the challenges that top the list, and what to do about them.

PBM Express Scripts shares findings from its new Drug Trend Report.

Prior authorizations are here to stay. Are yours working against you? Find out.

Model set to improve compliance, reduce costs, but reimbursement challenges remain.

Factors include rising costs of brand medications, increased specialty therapy use

New research suggests that mail-order pharmacies may help stroke survivors take their meds.

Analysis finds scientific validation of personalized medicine’s ability to improve patient outcomes.

: Proactive pharma tools help CVS manage pharmacy costs and focus on ensuring patients have access to the right drugs at the lowest cost.

Patients with chronic diseases who received a home visit in HealthPartners’ pilot MTM program reduced readmissions within the first year. Find out how.

PhRMA ad campaign features new patient and researcher stories.

PBMs, insurers use cautious approach when managing these cholesterol-lowering drugs.

Drug price increases can prove challenging for payers. Here’s six strategies to keep in your arsenal.

How at-risk negotiations with pharmaceutical manufacturers and medication adherence programs improve both sides of the healthcare value equation: patient outcomes and costs.

Opioids are powerful clinical tools that effectively treat pain and have a place in therapy, but it can be difficult to manage the dangers. Here's a look at some of the abuse-deterrent drugs on the horizon.

Prime Therapeutics has studied the costs and clinical events relationship among their members using a controlled substances (CS) score algorithm that identifies potential overuse/abuse of opioids/controlled substances.

A new survey reveals what employers' medical plans are doing to rein in specialty drug cost and utilization.